Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Volcano Corp. wins ruling

This article was originally published in The Gray Sheet

Executive Summary

Superior Court of Massachusetts rejects LightLab Imaging's claims for protection of five alleged trade secrets relating to laser technologies in a legal battle with Volcano and its wholly-owned subsidiary Axsun Technologies, Volcano announced Oct. 6. Requests from LightLab, a St. Jude Medical subsidiary, for permanent injunctions were also denied, the company noted. At the same time, a trial on remaining trade secret claims is yet to be scheduled. Volcano CEO Scott Huennekens said in a statement that the ruling "validates our position regarding these purported trade secrets" and that the company will "vigorously" defend itself against the remaining claims. A jury on Feb. 4 found that Volcano and Axsun misappropriated LightLab trade secrets, and that Volcano intentionally interfered with a contract under which Axsun supplied to LightLab tunable lasers for use in optical coherence tomography (OCT) systems. Volcano had said that it would appeal the jury verdict. LightLab filed its initial suit in January 2009 after Volcano acquired Axsun (1"The Gray Sheet" Feb. 15, 2010)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel